Nuclear Medicine

Varian nets FDA clearance for TrueBeam in osteoarthritis treatment

By AuntMinnie.com staff writers

Varian has received U.S. FDA clearance for the use of low-dose radiation therapy with its Varian TrueBeam radiotherapy systems.

March 19, 2026

TrueBeam radiotherapy system

TerraPower Isotopes to build Ac-225 facility in Philadelphia

By AuntMinnie.com staff writers

The new site will increase the company's actinium-225 (Ac-225) production capacity 20-fold.

March 18, 2026

JAMA study shows wide global variation in cardiac imaging radiation dose

By Kate Madden Yee

"Radiation doses varied significantly between imaging tests and among patients receiving the same tests," researchers reported.

February 25, 2026

Radiation Symbols Adobe Mia

Genetic mutations linked to poor outcomes in Pluvicto patients

TP53, PTEN, and RB1 mutations may serve as prognostic biomarkers.

February 23, 2026

The rise of theranostics: Part 7 -- Nuclear medicine technologists' rapid evolution

As theranostics gains speed, nuclear medicine technologists (NMTs) face a defining moment.

February 19, 2026

Image 3 Simulation Lab Courtesy Of Uab Feb 2026

Starget and CMIT collaborate

By AuntMinnie.com staff writers

The strategic collaboration aims to develop peptide radioligand therapies for cancer.

February 18, 2026

NorthStar inks Ac-225 supply deal with Bioemtech

By AuntMinnie.com staff writers

Initial deliveries will begin in the first quarter of 2026.

February 18, 2026

Journal of Nuclear Medicine names new editor in chief

By AuntMinnie.com staff writers

Herrmann is currently chair of nuclear medicine at the University of Duisburg-Essen in Germany.

February 11, 2026

Herrman Ken Thumbnail

Niowave inks Ac-225 supply deal with Novartis

By AuntMinnie.com staff writers

The agreement will provide Novartis with a supply of the medical isotope to support its growing portfolio of radioligand therapies.

February 11, 2026

Nucs AI establishes medical advisory board

By AuntMinnie.com staff writers

Nucs AI has formed its medical advisory board to ensure the company's AI theranostics tech is aligned with clinical practice.

January 29, 2026

Ai Abstract Researcher (1)

New study seeks to tailor RLT to individual patients

A new clinical trial aims to determine how doctors can optimize targeted radioligand therapy (RLT) for men with prostate cancer.

January 26, 2026

Georgia ProtonCare Center enters asset purchase agreement with Emory

By AuntMinnie.com staff writers

Georgia ProtonCare Center has entered into an asset purchase agreement with Emory University.

January 22, 2026

Business Development Graph Up 400

Page 1 of 441